PTEN mutations are common in sporadic microsatellite stable colorectal cancer

Publisher:
Nature Publishing Group
Publication Type:
Journal Article
Citation:
Oncogene, 2004, 23 (1), pp. 617 - 628
Issue Date:
2004-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2004000145.pdf129.03 kB
Adobe PDF
The tumour suppressor gene PTEN, located at chromosome sub-band 10q23.3, encodes a dual-specificity phosphatase that negatively regulates the phosphatidylinositol 3'-kinase (PI3 K)/Akt-dependent cellular survival pathway. PTEN is frequently inactivated in many tumour types including glioblastoma, prostate and endometrial cancers. While initial studies reported that PTEN gene mutations were rare in colorectal cancer, more recent reports have shown an approximate 18% incidence of somatic PTEN mutations in colorectal tumours exhibiting microsatellite instability (MSI+). To verify the role of this gene in colorectal tumorigenesis, we analysed paired normal and tumour DNA from 41 unselected primary sporadic colorectal cancers for PTEN inactivation by mutation and/or allelic loss. We now report PTEN gene mutations in 19.5% (8/41) of tumours and allele loss, including all or part of the PTEN gene, in a further 17% (7/41) of the cases.
Please use this identifier to cite or link to this item: